Antiviral T cells doing double-duty to fight cancer.

Local activation of virus-specific memory T cells can eliminate tumors without direct tumor-cell recognition, involving inflammatory responses and immune cell recruitment.

• Why it matters: This challenges the current understanding that T-cell therapies depend solely on tumor antigen recognition, suggesting a broader mechanism for antitumor immunity that could improve immunotherapy strategies.
• What they did: Smith and colleagues demonstrated that activating virus-specific memory T cells in situ triggers a multicellular inflammatory response, including IFNγ, TNF, nitric oxide, and myeloid cell recruitment, leading to tumor-cell death.
• The result: These findings suggest T cells can promote tumor elimination through immune organization rather than direct cytotoxicity, expanding the potential scope of T-cell-based cancer immunotherapy.